As South Korea's economy rebounds from the Asian financial crisis, its pharmaceutical and medical device markets are also rebounding due to increased demand and consumption. Part of the Korean government's economic reforms include the deregulation of its markets and promoting of foreign... Read More
Thanks to significant government reform efforts since 1998, the Malaysian economy has been able to rebound from the Asian currency crisis of 1997. The costs of healthcare in Malaysia are on the rise and the government is looking to cut healthcare expenditure,... Read More
This article contains a series of news briefs and updates with regard to Japan's medical device and pharmaceutical markets. Topics include: hospital roles in billing, reimbursing, and controlling medical equipment; pharmaceutical deregulation; liberalized procurement policy for medical products; and drug pricing policy. Read More
Despite the harsh effects of the Asian financial crisis, pharmaceutical markets in Asia still have a bright future. Thailand's pharmaceutical market suffered drops in 1997 and 1998 but renewed consumer demand and increased incomes are helping rebound the Thai pharmaceutical market growth... Read More
This article discusses some of the major issues facing foreign pharmaceutical companies looking to invest in the Indian market. India's pharmaceutical sector continues to grow at an annual rate of 15%-20%, and currently its pharmaceutical market is ninth in the world. Despite... Read More
Behind the U.S., Japan's medical market is the largest in the world. Many foreign medical companies, however, are worrying that Japan's struggling economy will shrink demand for their medical products in the country. Japan has been experiencing slow growth since the early... Read More
In Asia, health problems like cancer, heart disease, and automobile accidents are beginning to become the major causes of death, rather than infectious diseases. This major shift in health problems has pressed Taiwan's government to improve its healthcare system. Previously, Taiwan had... Read More
Although the mergers and acquisitions (M&A) plan announced by Glaxo Wellcome and Smithkline Beecham at the end of January 1998 ultimately failed, it demonstrated a strong worldwide tendency towards M&A in the pharmaceutical industry. The combined sales of these two companies, as... Read More
This article contains analyses of healthcare trends and policies, and the role of foreign medical companies in China, Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam. As Asia continues to be the fastest growing region in the world, economic... Read More
Growing healthcare reforms throughout Asia offer optimistic future prospects for multinational pharmaceutical companies. Southeast Asia has the world's fastest growing pharmaceutical market; while China's pharmaceutical sales have reached up to $10 billion and will continue to grow. Despite the issues of intellectual... Read More